BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32737803)

  • 1. Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth.
    McAnally H; Bonnet U; Kaye AD
    Pain Ther; 2020 Dec; 9(2):441-452. PubMed ID: 32737803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
    Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies.
    İspir GZ; Danışman M; Katar KS
    Curr Drug Res Rev; 2023 Nov; ():. PubMed ID: 38031769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Analgesia by Gabapentinoid Drugs: Involvement of Modulation of Synaptogenesis and Trafficking of Glutamate-Gated Ion Channels.
    Varadi G
    J Pharmacol Exp Ther; 2024 Jan; 388(1):121-133. PubMed ID: 37918854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 8. The Anti-Allodynic Gabapentinoids: Myths, Paradoxes, and Acute Effects.
    Alles SRA; Smith PA
    Neuroscientist; 2017 Feb; 23(1):40-55. PubMed ID: 27118808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
    Evoy KE; Covvey JR; Peckham AM; Reveles KR
    Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
    Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
    Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatalities associated with gabapentinoids in England (2004-2020).
    Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
    Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States.
    Bykov K; Bateman BT; Franklin JM; Vine SM; Patorno E
    JAMA Netw Open; 2020 Dec; 3(12):e2031647. PubMed ID: 33372975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
    Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
    Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling.
    Chen Y; Wu Q; Jin Z; Qin Y; Meng F; Zhao G
    Curr Med Chem; 2022 Aug; 29(30):5097-5112. PubMed ID: 35392779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gabapentinoid drugs and their abuse potential.
    Goins A; Patel K; Alles SRA
    Pharmacol Ther; 2021 Nov; 227():107926. PubMed ID: 34171338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misuse and abuse of pregabalin and gabapentin: cause for concern?
    Schifano F
    CNS Drugs; 2014 Jun; 28(6):491-6. PubMed ID: 24760436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020.
    Durand L; Keenan E; O'Reilly D; Bennett K; O'Hara A; Cousins G
    BMC Psychiatry; 2023 Oct; 23(1):725. PubMed ID: 37803285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
    Waddy SP; Becerra AZ; Ward JB; Chan KE; Fwu CW; Eggers PW; Abbott KC; Kimmel PL
    Am J Nephrol; 2020; 51(6):424-432. PubMed ID: 32428902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentinoid Prescribing for Carpal Tunnel Syndrome.
    Billig JI; Gunaseelan V; Yazdanfar M; Sears ED; Iwashyna TJ; Chang T; Waljee JF
    Hand (N Y); 2023 Jan; 18(1_suppl):106S-113S. PubMed ID: 35225033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.